InvivoGen Insight Newsletters

Latest Insight Newsletter

InvivoGen Insight Spring 2013

- Multi-PRR Agonists

- Toll-Like receptor 13

- STING Activation & Detection

- Review: Multi-TLR Agonists: Potential for Therapeutic Success

TLRs play a critical role in defense against invading pathogens but are also involved in other serious pathological processes, such as tumorigenesis. In view of this, TLR agonists have great potential as immunotherapeutics or vaccine adjuvants for the treatment of infectious diseases, cancer and autoimmune diseases....

Fall 2012 - Cytosolic DNA Sensors (CDSs): a STING in the tail

Summer 2012 - Lucia™, a novel secreted luciferase

Winter 2011 - Mycoplasma Detection and Elimination

Summer 2011 - Antibody and Vaccine adjuvants

Fall 2010 - Cytosolic dsDNA Sensors (CDS)

Spring 2010 - Lentiviral Vector Production

November 2009 - NLRP3 Inflammasome

Sept/Oct 2008 - DAMPs & DAMP Receptors

June/July 2008 - Vaccine Adjuvants

January 2008 - Immunoglobulin A

October 2007 - TLR9 Ligands

May 2007 - Toll-Like Receptor 4

December 2006 - RNA Interference

September 2006 - TLR7 and TLR8

May 2006 - Fc Fusion: pFUSE-Fc

November 2005 - Mycoplasma

September 2005 - TLR Signaling and IRF Activation Pathways

June 2005 - TLR Ligands

Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2013 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".